• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Premarket Approval (PMA)

  • Print
  • Share
  • E-mail
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC

New Search Back to Search Results
Note: this medical device record is a supplement. The device description may have changed. Be sure to look at the original PMA to get an up-to-date view of this device.
Classification Nameagent, absorbable hemostatic, collagen based
Generic Nameagent, absorbable hemostatic, collagen based
Regulation Number878.4490
2825 airview boulevard
portage, MI 49002
PMA NumberP050044
Supplement NumberS028
Date Received03/07/2014
Decision Date06/05/2014
Product Code
LMF[ Registered Establishments with LMF ]
Advisory Committee General & Plastic Surgery
Supplement Typereal-time process
Supplement Reason change design/components/specifications/material
Expedited Review Granted? No
Combination Product No
Approval Order Statement 
Approval for the following changes to the ba-02 delivery system component of vitagel rt3 surgical hemostat: replacement of the current syringe clip and syringe support components with a twin syringe dispenser, replacement of the current joiner component with a rotating luer adapter (syringe adapter) to the distal luer connections of the extended applicators, changes in materials of construction and manufacturers of the aforementioned components and update in the primary packaging. Additionally, the optional extended applicator delivery accessories of the vitagel rt3 surgical hemostat, malleable extended applicator (mea) and laparoscopic extended applicator (lea), as modified, will be marketed under the trade names reach 9 malleable applicator and reach 38 laparoscopic applicator, respectively.